openPR Logo
Press release

Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, Posterior uveitis, and Pan uveitis), By Cause (Infectious, and Non Infectious), By Condition (Acute, Chronic, and Recurrent), By Drug (Corticosteroids, Immunosuppressants, Mon

10-20-2017 07:01 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Uveitis Treatment Market By Indication (Anterior uveitis,

Uveitis is a combined condition of inflammation and swelling of the eyes. Uvea comprises of three parts Iris, ciliary body (small ring shape muscles behind iris and choroid), and choroid (it is the layer of tissue between retina and sclera), which decides eye color and helps eye in focusing and absorbing light. Uveitis can be caused by eye problems, autoimmune disease, HIV, multiple sclerosis, reactive arthritis, Kawasaki disease tuberculosis, and syphilis. Uveitis can affect people between the ages of 16 to 60 years, sometimes it may lead to permanent loss of vision. According to the National Center for Biotechnology Information (NCBI), uveitis counts for 10% to 15% of overall blindness. Treatments available for of uveitis include steroids, immunosuppressant, and monoclonal antibodies. Surgeries are performed in rare cases. Various pharmaceutical companies are working on R&D to launch new and effective medication for the treatment of uveitis, which is expected to boost the uveitis market.

Request Sample Copy of the Report: https://www.coherentmarketinsights.com/insight/request-sample/842

Uveitis treatment market taxonomy

By Indication

Anterior uveitis
Intermediate uveitis
Posterior uveitis
Pan uveitis
By Cause

Infectious
Non infectious
By Condition

Acute
Chronic
Recurrent
By Drug

Corticosteroids
Immunosuppressant
Monoclonal antibodies
Cycloplegic agents
Antibodies
Antiviral
Antifungals
Analgesics

Research and development fuels the growth of uveitis treatment market

Several companies such as Pfizer Inc., pSivida Corp., and Novartis AG are investing in R&D to produce novel drug for the treatment of uveitis. There are few drugs already in pipeline such as Sirolimus, dexamethasone phosphate, rituximab, which will boost the uveitis treatment market. Increase in demand of generic drugs is also expected to support the growth of uveitis treatment market. Uveitis are caused by infections such as cat-scratch disease, herpes zoster, and ulcerative colitis. According to NCBI report, 17.4 to 52.4 cases per 100000 person every year takes place and it causes 2.8 -10% of legal blindness in the U.S annually. Corticosteroids are the most commonly used treatment for uveitis as compared to other drugs such as biologics, immunosuppressant. After corticosteroids antibiotics and monoclonal antibodies are mostly used for the treatment. Side effects of medication such as blurred vision, weight gain, insomnia, and increased appetite could be the major restraint for the growth of the uveitis market. Lack of awareness in emerging economies can lead to chronic eye disease and vision loss.

Developed regions are major growth engines of the uveitis treatment market

Market comprises of regions that is North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. North America is the largest region and emerging market for uveitis treatment globally. Europe is the second largest emerging market which support the growth of global uveitis treatment market. After Europe, Asia pacific is the third largest growing market which includes emerging countries like India and China, owing to the increase in healthcare facilities and awareness people among the people, which will support the growth of uveitis treatment market.

Browse Full Report at: https://www.coherentmarketinsights.com/ongoing-insight/uveitis-treatment-market-842

Key players and major acquisitions to support the growth of uveitis treatment market

Key players operating global uveitis market include Allergan, Novartis AG, Valeant Pharmaceuticals International, AbbVie Inc., Eyegate Pharmaceuticals Inc., and pSivida corp. Allergan, Novartis and Valeant Pharmaceuticals International, Inc. are most dominant players in the market. Major acquisition takes place in this market include

In 2016, Allergan acquired a gene therapy company name Retrosome Therapeutics, which strengthen their ophthalmology drug pipeline. In the same year Allergan launched uveitis drug Taytulla.
In 2016, Novartis acquired Encore vision, which help to enhance their ophthalmology drug pipeline
In 2015, Eyegate signed a licensing agreement with valeant for effective combination of drugs for uveitis and in 2016 they acquired Jade Therapeutics Inc.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:

1001 4th Ave, #3200 Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Treatment Market By Indication (Anterior uveitis, Intermediate uveitis, Posterior uveitis, and Pan uveitis), By Cause (Infectious, and Non Infectious), By Condition (Acute, Chronic, and Recurrent), By Drug (Corticosteroids, Immunosuppressants, Mon here

News-ID: 779617 • Views: 381

More Releases from Coherent Market Insights

Melatonin Market 2021-2027 COVID-19 Impact and Global Analysis By-Natrol Inc., N …
Coherent Market Insights adds a new market research report to the database that provides an in-depth analysis of the keyword. The study's goal is to provide information on global market growth projections based on current and historical industry growth evaluations, as well as the Melatoninplace's most recent scenario. The true data in the report is based on broad research definitions and subordinate research definitions. The data-driven insights are excellent resources
Converting paper Market Growth Factor with Regional Forecast, Market Size, Top V …
Coherent Market Insights Report published new research on the Converting paper Market Report covering the micro-level of analysis by competitors and key business segments (2022-2028). The Converting paper explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Global Converting paper Market
Rigid Plastic Packaging Market 2022 Size, Growth Share, Future Trends, Price, Bu …
Coherent Market Insights Report published new research on the Rigid Plastic Packaging Market Report covering the micro-level of analysis by competitors and key business segments (2022-2028). The Rigid Plastic Packaging explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Global Rigid
Gellan Gum Market 2022 - Current Trends Competitive Landscape, Sales, Share, Seg …
Coherent Market Insights Report published new research on the Gellan Gum Market Report covering the micro-level of analysis by competitors and key business segments (2022-2028). The Gellan Gum explores a comprehensive study on various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Global Gellan Gum Market

All 5 Releases


More Releases for Uveitis

Uveitis Treatment Market: Global Market Of Uveitis Disease Is Estimated To Reach …
Uveitis Treatment Market Precision Business Insights (PBI) in its report titled “Global Uveitis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Uveitis is swelling of the middle layer of the eye,
Uveitis Therapeutic and Disease Pipeline Review H1
Summary Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye and sensitivity to light. The predisposing factors include having an infection, an autoimmune or
Anterior Uveitis Market to Perceive Substantial Growth by 2024
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Uveitis Market 2018 Global Analysis, Opportunities and Forecast to 2026
Summary Uveitis is an inflammatory condition of the eye affecting mainly the uvea. It encompasses a heterogeneous collection of disorders characterized by ocular inflammation. Currently, there is only a limited number of approved drugs for the treatment of uveitis. Based on the diverse nature of uveitis , there is a high unmet need for varied therapy approaches. Significant efforts are being made to develop new treatments for uveitis, as current pharmacologic
Anterior Uveitis Market: An Industry Case Study
Uveitis is the inflammation of the uveal region of the eye, most commonly by an infection. Uvea is a group of pigmented and non pigmented tissues lying in the middle among the three layers that make the eye. Uvea again consists of three layers: iris, cilliary body and the choroid. The uvea is also known as the uveal tract in some medical circles, this tract is necessary for the nutrition
Global Uveitis Treatment Industry : Market Development, Analysis and Overview 20 …
Researchmoz added Most up-to-date research on "Global Market Study on Uveitis Treatment: Europe Market Projected to Represent Market Attractiveness Index of 1.3" to its huge collection of research reports. Persistence Market Research presents a comprehensive study of the global uveitis treatment market in a new publication titled Uveitis Treatment Market: Global Industry Analysis and Forecast, 20162024. The report forecasts the performance of the global uveitis treatment market across different geographical locations and